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a b s t r a c t
Background: We studied patients with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) associated with or without lymphoma and measured risk factors suggestive of an underlying lymphoma and follow-up outcomes. Methods: CLIPPERS patients associated with or without lymphoma were included into this study. Clinical presentations were documented, risk factors suggestive of an underlying lymphoma were tested, and prognostic differences in terms of death were compared. Results: Ten patients had a diagnosis of CLIPPERS associated with lymphoma, with 6 B-cell non-Hodgkin lymphoma, 2 T-cell non-Hodgkin lymphoma and 2 Hodgkin lymphoma. Using multivariate logistic analysis, the following 3 independent risk factors were found to be related to a final diagnosis of lymphoma: hyperreflexia (HR 16.56; 95% CI 1.03-265.29; p = 0.032), elevated protein in CSF (HR 11.59; 95% CI 1.24-108.39; p = 0.047), and recurrences between 2 months and 1 year after treatment (HR 29.27; 95% CI 2.09-409.58; p = 0.012). The model calibration was satisfactory (p = 0.392 with the Hosmer-Lemeshow test), and the discrimination power was good (area under the receiver operating characteristic curve 0.921; p < 0.001, 95% CI 0.826-1.000). Patients with CLIPPERS associated with lymphoma had higher mortality rate and lymphoma was a significant predictor of total mortality (HR 0.040; 95% CI 0.006-0.262; p = 0.001). Conclusions: Hyperreflexia, elevated protein in CSF and recurrences between 2 months and 1 year after treatment are risk factors suggesting an underlying lymphoma. Relapses during high-dose steroids maintenance therapy can be indicative of lymphoma, too. Patients having CLIPPERS associated with lymphoma have a worse prognosis than those without lymphoma. 
Background
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is a kind of rare disease neurologists may encounter in clinical practice. Since first described, CLIPPERS has attracted worldwide attention [1] [2] [3] . Meanwhile, however, more and more reports about lymphoma mimicking the manifestations of CLIPPERS followed. Patients diagnosed as CLIPPERS associated with lymphoma often had poor prognoses rather than the benign processes in CLIPPERS patients without lymphoma [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Different treatment strategies should be adapted against these two different diagnoses. Therefore, it is important to recognize the patients associated with lymphoma at early stage and get timely assistance from hematologists.
In 2010, chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids was first defined as a rare central nervous system (CNS) inflammatory syndrome by Pittock and colleagues [1] . This condition prominently involves the brainstem and the pons. CLIPPERS manifests characteristically in a subacute manner including gait ataxia, dysarthria, diplopia and altered facial sensation. The magnetic resonance imaging (MRI) shows a punctate and nodular pattern of gadolinium enhancement ''peppering" in the pons, brainstem, white matter, and other adjacent structures. Perivascular lymphohistiocytic and predominant T cells infiltration in brain biopsy specimen is another striking characteristic. As the name implies, CLIPPERS patients present a favorable and dependent response to steroids therapy [2, 3] .
Lymphoma is a hematological malignancy, the diagnosis of which requires a biopsy and pathological examination. Left undiagnosed or untreated, lymphomas (especially aggressive lymphomas) have high mortality rates, but understanding the pathogenesis and progression of lymphoma allows treatments that offer long periods of disease free survival [14] . Thus, differences or similarities in terms of baseline characteristics, clinical features, MRI findings, pathological manifestations, treatments and outcomes in CLIPPERS patients associated with or without lymphoma need to be compared, and risk factors suggestive of underlying lymphoma need to be identified.
Methods

Data collection
We systematically searched PubMed for studies regarding CLIP-PERS until September 2018. Studies that met the following criteria were included in the analysis: (I) original articles or case reports; (II) study with human subjects; (III) study reporting CLIPPERS patients associated with lymphoma or without lymphoma; (IV) observed data included clinical features and/or treatment outcomes. All the studies were included without language restriction. Studies without separating lymphoma from non-lymphoma patients were excluded. Four investigators (Liu XH, Jin F, Liu MX and Zhang M) independently screened the titles and abstracts of the studies to initially screen for eligible studies. Eligible studies from the initial screening were reviewed in full and assessed for compliance with the inclusion criteria. Reference lists from previous reviews and all associated studies were individually searched for additional studies. Discrepancies were resolved via consensus. In the case of studies with overlapping populations, only the study with the largest number of patients was included. The eligible studies were reviewed for clinical manifestations, neuroimaging and pathological characteristics, treatment strategies and prognoses.
Some details need to be clarified in data extraction. Firstly, the patients included do not have to all conform to the proposed and updated diagnostic criteria for CLIPPERS. Because there have been no standardized or widely accepted diagnostic criteria so far. Each of them is imperfect. Thus, we agree with the authors' original diagnoses only if no obvious flaws existed. Secondly, all the clinical symptoms and physical signs extracted were those at the initial presentation of CLIPPERS. Thirdly, the neuroimaging results could not be analyzed quantitatively and the specific influenced regions could not be located or numbered because of the limitations of reported data. Thus, the neuroimaging alternations indicative of transformation into lymphoma were summarized.
Statistical analysis
Statistical analysis was performed using SPSS 22.0 (SPSS Inc., Chicago, IL, USA). Mean, SDs, and percentages were used to describe the characteristics of the study population. All possible risk factors associated with a final lymphoma diagnosis were screened using Chi-square or Fisher exact test for categorical variables and t test for continuous variables where appropriate. Variables with p > 0.1 were excluded. For identification of independent predictors of lymphoma, a multivariate logistic regression model was created introducing significant univariate variables as covariates with the stepwise enter method. A Hosmer-Lemeshow test was used to evaluate calibration and the area under the receiver operating characteristic curve was used to assess model discrimination between patients with and without lymphoma. Multicollinearity of the identified risk factors was confirmed with tolerance and inflation statistics. The prognostic differences in terms of death between patients associated with and without lymphoma were analyzed by Kaplan-Meier survival analysis. Two-tailed P-value less than 0.05 was considered statistically significant.
Results
Patient characteristics
By September 2018, a total of 88 cases had been reported, with 10 of them associated with lymphoma [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . An upward tendency of CLIPPERS followed since the first description in 2010, indicating the rising awareness of this disease entity. Most of the patients were European (48/88), Asian (13/88), American (10/88), and Australian (8/88). The mean age of the patients at disease onset was 49.8 years. Male occupied 71.6% (63/88) of the patients. There were no significant differences in terms of age and sex between patients with and without lymphoma ( Table 1) .
Subacute gait ataxia marked the clinical onset in nine of the ten cases with CLIPPERS associated with lymphoma. The ataxia was accompanied by symptoms related to brainstem, cerebellar, cranial nerve, and spinal cord involvement or extensions into other structures of the nervous system (Tables 2A and 2B ), including dysarthria (n = 6), diplopia (n = 5), increased deep tendon reflexes (n = 4), dysphagia (n = 3), pyramid signs (n = 3), nystagmus (n = 2), facial sensory losses (n = 2), facial nerve palsies (n = 2), urinary/fecal incontinence (n = 2), paralysis (n = 2), altered sensation of extremities (n = 2), weight loss (n = 2), and cognitive deficits (n = 1). The frequencies of existence of the symptoms were not significantly different from CLIPPERS without lymphoma, except for pyramid signs (3/10 vs 3/78, p = 0.018) and increased deep tendon reflexes (4/10 vs 5/78, p = 0.006) ( Table 1) . It is worth noting that, for T-cell lymphoma or Hodgkin's lymphoma, the neurological symptoms developed 1 -16 years after lymphoma. On the other hand, in all the cases diagnosed as B-cell lymphoma, CLIPPERS was the preceding diagnosis several months before lymphoma (Table 2) .
Cerebrospinal fluid (CSF) abnormalities in patients with lymphoma-associated CLIPPERS were found in 9 of 10 patients tested: elevated protein in 9 patients (0.63-1.3 g/L) and pleocytosis in 4 patients (5-108/mm 3 ). Abnormal CSF oligoclonal bands were not reported in these patients ( ) and abnormal elevations in CSF oligoclonal bands in 19 of 38 patients tested. Apart from elevated protein (9/10 vs 38/78, p = 0.033), there were no statistically significant differences in CSF parameters between lymphoma-associated and nonlymphoma CLIPPERS patients (Table 1) . To be specific, elevated proteins in CSF were observed in almost all patients associated with lymphoma no matter what kind of lymphoma the patient developed. A majority of them (7/10) showed fairly high CSF protein level (>0.9 g/L). However, only half non-lymphoma patients showed elevated proteins, and in most of them we only found mild protein elevation. Few non-lymphoma CLIPPERS reached a CSF protein level of 0.9 g/L.
MRI findings in CLIPPERS showed a very characteristic lesion pattern: punctate and/or curvilinear gadolinium enhancement with a perivascular pattern centered on the pons. The lesions might extend into other adjacent CNS structures. The typical radiological picture in a salt-and-pepper like appearance could also initially be detected in almost all the CLIPPERS patients associated with lymphoma. At least two anatomical locations were affected in 9 of 10 patients, mainly involving the pons (n = 9), cerebellum (n = 5), medulla (n = 4), midbrain (n = 3), spinal cord (n = 3), cerebral hemispheres (n = 3) and basal ganglia (n = 2). These findings were in accordance with the locations CLIPPERS without lymphoma often affected.
However, some neuroimaging hints suggestive of an alternative diagnosis may occur during the later disease course, especially in those patients diagnosed as having B-cell lymphoma afterwards. They deserve a special mention, as follows. In 10 cases associated with lymphoma, 7 cases were confirmed by biopsy pathology, including 5 cases demonstrated as having pathological consistency with B-cell lymphoma later. Meanwhile, biopsy rate was similar (40/73) in CLIPPERS patients without lymphoma (Table 1 ). Original histological findings in patients with or without lymphoma were invariably compatible with CLIPPERS features, showing perivascular lymphohistiocytic infiltrates with predominance of CD4+ T-cells, without evidence of lymphoma.
However, the final diagnosis turned out to be lymphoma, including 8 cases of Non-Hodgkin's lymphoma (6 B-cell lymphoma and 2 Tcell lymphoma) and 2 cases of Hodgkin's lymphoma. As for the aggressiveness of lymphoma, 7 of the 8 patients with NonHodgkin's lymphoma were diagnosed as invasive lymphoma, except for the patient with mycosis fungoides-type cutaneous Tcell lymphoma. Few patients had had prior cutaneous, mediastinal or lymphonodal lesions, but all these patients had the disease in remission and no lesions at presentation when CLIPPERS associated with lymphoma was diagnosed [9, 11, 12] .
When CLIPPERS syndrome was suspected, all of the 10 cases with CLIPPERS associated with lymphoma received immunosuppressive therapy as the initial therapeutic regime, mainly basing on intravenous or oral high-dose steroid therapy. They entirely showed significant clinical and MRI improvement quickly after the initial therapy, which was similar to non-lymphoma patients. Both improvement within one week after treatment (2/6 vs 10/24, p = 1.0) and recurrences within 2 months after treatment (1/9 vs 5/41, p = 1.0) were similar between them. However, as time passed by, the circumstance seemed to be different in lymphoma and non-lymphoma patients. Patients associated with lymphoma had worse prognosis, with significantly higher 1-year mortality rate (4/10 vs 1/68, p = 0.001). Relapses between 2 months and 1 year after treatment were significantly more in patients associated with lymphoma (4/9 vs 5/46, p = 0.046). Although total relapses >1 was similar in both groups (2/10 vs 23/63, p = 0.51), but of the 78 non-lymphoma patients, 48 had relapses, none occurred when chronic corticosteroid therapy was maintained above 30 mg/d (Tables 1 and 2 ). In addition, they showed dramatic improvement by GCS treatment after relapses, only 2 deaths were reported.
As we mentioned above, the course of disease differed widely in different kinds of lymphoma. For B-cell lymphoma, 6 of 6 patients suffered at least one relapse, among which 5 patients relapsed within 6 months. Meanwhile, 4 of 6 patients suffered relapses on high-dose maintenance treatment (prednisolone >30 mg/d) and finally all of them progressed into a state where no further clinical (Table 2) . Lymphoma was often discovered by biopsy at this time. Furthermore, 5 of 6 patients died because of disease progression, among which 4 patients died within a year and 1 patient died after 2 years. For T-cell lymphoma or Hodgkin's lymphoma, low-dose GCS or immunosuppressant could take good control of the disease and no relapse occurred.
Risk factors associated with lymphoma
Fifty-five patients with confirmed diagnosis were eligible for further analysis. Tables 2 and 3 Abbreviations: OR, odds ratio; CI, confidence interval; CSF, cerebrospinal fluid. 
Clippers associated with or without lymphoma and clinical outcomes
Compared to patients without lymphoma, patients with CLIP-PERS associated with lymphoma had higher mortality rate (Fig. 2) . Subjects with lymphoma had worse clinical outcomes, in contrast to those with CLIPPERS without lymphoma. The median survival time of patients associated with lymphoma was 10.5 months. Lymphoma was a significant predictor of total mortality (HR 0.040; 95% CI 0.006-0.262; p = 0.001).
Discussion
Diagnosis of patients with CLIPPERS is clinically challenging because of the complexity of differential diagnoses, especially when it comes to lymphoma [1] [2] [3] . If a patient was diagnosed as having CLIPPERS associated with lymphoma, the patient was often severely ill and had a bad clinical outcome. As suggested by our study, patients with CLIPPERS associated with lymphoma had higher mortality rate and lymphoma was a significant predictor of total mortality. Meanwhile, relapses were often experienced when prednisolone was over 30 mg/d and treatment respondences to immunosuppressive therapy were often observed getting worse and worse in patients associated with lymphoma. This might indicate that relapses on high dose maintenance treatment or no response to further immunosuppressive therapy was a ''warning sign" for the diagnosis of isolated CLIPPERS and held possibility of lymphoma. When lymphoma was suspected, usage of further corticosteroid administration should be cautious so as not to delay the appropriate treatment towards the disease. A prompt diagnosis and targeted treatment were vital to saving the lives of those patients.
However, diagnosis of these patients was no easy task: symptoms and noninvasive measurements such as brain MRI were not enough to yield a confirmed diagnosis because these findings were usually similar in patients associated with and without lymphoma, as indicated in our study. No specific serum autoimmune antibodies related to CLIPPERS had been detected so far [2] . Even the invasive procedures like brain biopsy were not sufficient for diagnosis or not available due to the technical limitations and possible complications including hemorrhage, intracranial hypertension and edema [60] . On the other hand, many patients deteriorated so quickly that a delay in diagnosis could cause terrible consequences. Therefore, hints suggestive of an underlying lymphoma from different aspects of disease such as baseline characteristics, clinical features, MRI findings, pathological manifestations, and treatment respondences were urgently needed to be identified. This is the first study to identify significant independent risk factors: recurrences between 2 months and 1 year after treatment, elevated protein in CSF, and increased deep tendon reflexes, suggesting the presence of an underlying lymphoma. Firstly, recurrences between 2 months and 1 year after treatment was an indicator of lymphoma. Meanwhile, however, relapses within 2 months after treatment did not differ significantly between two groups. This might be explained by the following reasons. On one hand, high-grade evidence regarding the appropriate approach to treatment is limited at present because of the low incidence. Standardized recommendations for treatment strategy have not been established by now. In many cases, initial usage of prednisone was not in sufficient dosage and/or tapering of prednisone was too fast. Taking the relapsing-remitting feature of CLIPPERS into consideration, it is not surprising that five cases with CLIPPERS without lymphoma relapsed within 2 months after treatment [61] . On the other hand, glucocorticoids could work to some extent in the treatment of lymphoma by inducing the apoptosis of healthy and malignant lymphocytes [62] . Glucocorticoids were included in the common CHOP regimen for non-Hodgkin lymphoma and ABVD regimen for Hodgkin lymphoma. But glucocorticoids could not stop the disease from being exacerbated if an underlying lymphoma existed. Therefore, more relapses occurred for the first time after 2 months, which could be reminiscent of diagnosis as CLIPPERS associated with lymphoma. Recent studies indicated that expression of programmed death ligand 1 (PD-L1) by lymphoma cells and tumor-associated macrophages mediated the trafficking of tumor-infiltrating lymphocytes, which might explain the immune-escape process of primary central nervous system lymphomas. Meanwhile, recent clinical trials of the blockade of the programmed death protein 1 (PD-1)/PD-L1 pathway using antibodies demonstrated that this approach had significant efficacy in various malignant tumors, including primary central nervous system lymphomas. Thus, the usage of PD-1/PD-L1 pathway antibodies in CLIPPERS associated lymphoma is worth investigating [63] . Secondly, most CSF proteins originate in the blood serum regardless that a small part of them are synthesized within the CNS or the meninges [64] [65] [66] . They pass through blood-CNS barriers into CNS fluids. Elevated protein levels in the CSF are thought to be caused by increased vascular permeability and dysregulation of the blood-brain barrier. For patients associated with lymphoma, the two presumed underlying mechanisms for the reason why they showed high CSF protein levels might be angiogenesis and inflammation [67] . CNS lymphoma triggered great inflammatory response and caused angiogenesis, which would increase vascular permeability and give rise to high CSF protein levels. For nonlymphoma CLIPPERS, the disease etiology is still not clear enough. Pittock et al. suggested that CLIPPERS might be an autoimmune disorder triggered by an unknown perivascular antigen [1] , while others thought CLIPPERS might be a pre-lymphoma state [68] and represented an effective host immune response. Both the two conjectures indicated that CLIPPERS might be a disease resulted from chronic and mild host inflammation that was weaker compared to lymphoma associated inflammation. Thus patients with isolated CLIPPERS presented slight dysregulation of the blood-brain barrier and showed normal or mild increased CSF protein levels. In addition, Wen Zheng et al. found that the CSF protein subtypes were similar among lymphoma patients [69] . Therefore, further analysis of the CSF protein subtypes might be of great need to distinguish lymphoma associated CLIPPERS from nonlymphoma CLIPPERS. Thirdly, increased deep tendon reflexes are defined as over-active or over-responsive reflexes, which usually indicate an interrupting of corticospinal and other descending pathways that influence the reflex. These are due to a suprasegmental structural lesion (of myelin, axons, or both), that is, a lesion above the level of the spinal reflex pathways such as cortex, brain stem, internal capsule and spinal cord [70] . As we all know, the radiological distribution of CLIPPERS is focused in the pons and adjacent rhombencephalic structures such as the cerebellar peduncles, medulla and the midbrain [2, 3] . Accordingly, CLIPPERS patients should have a certain amount of symptoms of increased deep tendon reflexes. However, our study identified these symptoms as an independent predictor of lymphoma via multivariate analysis. Here are some probable explications. It could not be ruled out that our sample size was not large enough and there would be systematic errors. Meanwhile, as the name suggests, CLIPPERS demonstrated dense lymphocytic inflammation with perivascular predominance, isolation focal demyelination in CLIPPERS was not seen [2] . Besides, there was relative axonal preservation [71] . As for lymphoma, demyelination could be found and represent a sentinel lesion that eventually progressed to lymphoma [72] . Although the relationship between increased deep tendon reflexes and CLIP-PERS associated with lymphoma was uncertain, we should be vigilant when CLIPPERS patients present with increased deep tendon reflexes. It's worth mentioning that, univariate analysis revealed the positive status of pyramid signs was also associated with lymphoma. Since both pyramid signs and increased deep tendon reflexes were presentations of long tract signs, we suspected that CLIPPERS associated with lymphoma may have more long tract symptoms as Dudesek proposed [3] . Finally, neuroimaging hints suggestive of progression into lymphoma had been found as we mentioned above. Thus, changes in MRI characteristics should be closely monitored. Considering that 5 of 6 patients turned into Bcell lymphoma within 5 to 10 months after the preceding diagnosis as CLIPPERS, we would recommend examination of brain MRI in a short time interval within the first year after CLIPPERS. Our study had some limitations. Firstly, it is a retrospective study and data collection bias are evident. Secondly, the clinical data were not reported consistently throughout the studies. Thus, some of them might be falsely interpreted. Thirdly, the sample size of CLIPPERS patients was rather small. One study with relatively large sample size but without separating lymphoma-associated patients from non-lymphoma patients was excluded [71] . Such a sample size may cause bias in data processing. It may not be strong enough to support the increased CSF protein and increase in deep tendon reflexes as the discriminating criterion because the statistical significance was relatively weak. More reports of CLIPPERS patients associated with or without lymphoma are warranted. Fourthly, hyperreflexia is a somewhat subjective sign that might be reported differently by different observers. The influence of subjectivity can not be fully ruled out. Fifthly, it is possible that patients diagnosed with CLIPPERS subsequently developed lymphoma after their case report was published, which might skew the findings. Finally, lymphomas are heterogeneous and a rough binary classification of patients associated with or without lymphoma may oversimplify our conclusions.
Conclusions
Whether CLIPPERS represents an actual new disease or a syndrome including heterogeneous disorders or the prestage of other diseases like lymphoma remains debated. This study, based on recently available data, revealed that patients with CLIPPERS associated with lymphoma presented much worse clinical outcomes. Furthermore, it is the first study to provide risk factors suggestive of an underlying lymphoma in CLIPPERS patients. A 3-variable model (increased deep tendon reflexes, elevated protein in CSF, and recurrences between 2 months and 1 year after treatment) may predict lymphoma in CLIPPERS patients. Meanwhile, the observed phenomenon that no relapse occurred with prednisone over 30 mg/d in non-lymphoma patients can make the clinicians cautious lymphoma if the disease relapsed at high-dose steroids therapy.
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